Nuclear phosphoinositide 3-kinase C2β activation during G2/M phase of the cell cycle in HL-60 cells

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1631, Issue 1, 2003, Pages 61-71

  Višnjić, Dora ^a   Ćurić, Josip ^b   Crljen, Vladiana ^a   Batinić, Drago ^b   Volinia, Stefano ^c   Banfić, Hrvoje ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Calpain; Cell cycle; HL 60 cells; Nuclei; Phosphoinositide 3 kinase C2

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; APHIDICOLIN; CALPASTATIN; CALPEPTIN; PHOSPHATE; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL NUCLEUS MEMBRANE; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; IN VITRO STUDY; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 12244275663     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(02)00356-6     Document Type: Article

References (41)

1. Divecha N., Banfic H., Irvine R.F. The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-I) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase C to the nucleus. EMBO J. 10:1991;3207-3214.
2. Banfic H., Zizak M., Divecha N., Irvine R.F. Nuclear diacylglycerol is increased during cell proliferation in vivo. Biochem. J. 290:1993;633-636.
3. York J.D., Majerus P.W. Nuclear phosphatidylinositols decrease during S-phase of the cell cycle in HeLa cells. J. Biol. Chem. 269:1994;7847-7850.
4. Clarke J.H., Letcher A.J., D'santos C.S., Halstead J.R., Irvine R.F., Divecha N. Inositol lipids are regulated during cell cycle progression in the nuclei of murine erythroleukaemia cells. Biochem. J. 357:2001;905-910.
5. 2/M phase transition. J. Biol. Chem. 272:1997;26313-26317.
6. 2/M phase transition of cell cycle. J. Biol. Chem. 271:1996;15045-15053.
7. Goss V.L., Hocevar B.A., Thompson L.J., Stratton C.A., Burns D.J., Fields A.P. Identification of nuclear beta II protein kinase C as a mitotic lamin kinase. J. Biol. Chem. 269:1994;19074-19080.
8. Vanhaesebroeck B., Waterfield M.D. Signalling by distinct classes of phosphoinositide 3-kinases. Exp. Cell Res. 253:1999;239-254.
9. Martelli A.M., Borgatti P., Bortul R., Manfredini M., Massari L., Capitani S., Neri L.M. Phosphatidylinositol 3-kinase translocates to the nucleus of osteoblast-like MC3T3-E1 cells in response to insulin-like growth factor I and platelet-derived growth factor but not to the proapoptotic cytokine tumor necrosis factor alpha. J. Bone Miner. Res. 9:2000;1716-1730.
10. Tanaka K., Horiguchi K., Yoshida T., Takeda M., Fujisawa H., Takeuchi K., Umeda M., Kato S., Ihara S., Nagata S., Fukui Y. Evidence that a phosphatidylinositol 3,4,5-trisphosphate-binding protein can function in nucleus. J. Biol. Chem. 274:1999;3919-3922.
11. Metjian A., Roll R.L., Ma A.D., Abrams C.S. Agonists cause nuclear translocation of phosphatidylinositol 3-kinase gamma. A betagamma-dependent pathway that requires the p110gamma amino terminus. J. Biol. Chem. 274:1999;27943-27947.
12. Bacqueville D., Deleris P., Mendre C., Pieraggi M.T., Chap H., Guillon G., Perret B., Breton-Douillon M. Characterization of a G protein-activated phosphoinositide 3-kinase in vascular smooth muscle cell nuclei. J. Biol. Chem. 276:2001;22170-22176.
13. Volinia S., Dhand R., Vanhaesebroeck B., MacDougall L.K., Stein R., Zvelebil M.J., Domin J., Panaretou C., Waterfield M.D. A human phosphatidylinositol 3-kinase complex related to the yeast Vps34p-Vps15p protein sorting system. EMBO J. 14:1995;3339-3348.
14. Domin J., Pages F., Volinia S., Rittenhouse S.E., Zvelebil M.J., Stein R.C., Waterfield M.D. Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem. J. 326:1997;139-147.
15. Brown R.A., Ho L.K., Weber-Hall S.J., Shipley J.M., Fry M.J. Identification and cDNA cloning of a novel mammalian C2 domain-containing phosphoinositide 3-kinase, HsC2-PI3K. Biochem. Biophys. Res. Commun. 233:1997;537-544.
16. Arcaro A., Volinia S., Zvelebil M.J., Stein R., Watton S.J., Layton M.J., Gout I., Ahmadi K., Downward J., Waterfield M.D. Human phosphoinositide 3-kinase C2beta, the role of calcium and the C2 domain in enzyme activity. J. Biol. Chem. 273:1998;33082-33090.
17. Ono F., Nakagawa T., Saito S., Owada Y., Sakagami H., Goto K., Suzuki M., Matsuno S., Kondo H. A novel class II phosphoinositide 3-kinase predominantly expressed in the liver and its enhanced expression during liver regeneration. J. Biol. Chem. 273:1998;7731-7736.
18. Sindic A., Aleksandrova A., Fields A.P., Volinia S., Banfic H. Presence and activation of nuclear phosphoinositide 3-kinase C2beta during compensatory liver growth. J. Biol. Chem. 276:2001;17754-17761.
19. Visnjic D., Crljen V., Curic J., Batinic D., Volinia S., Banfic H. The activation of nuclear phosphoinositide 3-kinase C2beta in all-trans-retinoic acid-differentiated HL-60 cells. FEBS Lett. 529:2002;268-274.
20. Fields A.P., Pettit G.R., May W.S. Phosphorylation of lamin B at the nuclear membrane by activated protein kinase C. J. Biol. Chem. 263:1988;8253-8260.
21. Wakabayashi T., Asano M., Kurono C., Kimura H. Effects of extremely low concentrations of glutaraldehyde together with shortening of fixation time on the maintenance of various enzymes activities. J. Histochem. Cytochem. 23:1975;632-634.
22. Nordlie R.C., Arion W.R. Liver microsomal glucose-6-phosphatase, inorganic pyrophosphatase, and pyrophosphate-glucose phosphotransferase. Effects of adrenalectomy and cortisone administration on activities assayed in the absence and presence of deoxycholate. J. Biol. Chem. 240:1965;3479-3484.
23. Burnside J., Schneider D.L. Characterization of the membrane proteins of rat liver lysosomes. Composition, enzyme activities and turnover. Biochem. J. 204:1982;525-534.
24. Zhang J., Banfic H., Straforini F., Tosi L., Volinia S., Rittenhouse S.E. A type II phosphoinositide 3-kinase is stimulated via activated integrin in platelets. A source of phosphatidylinositol 3-phosphate. J. Biol. Chem. 273:1998;14081-14084.
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 227:1970;680-685.
26. Vann L.R., Wooding F.B.P., Irvine R.F., Divecha N. Metabolism and possible compartmentalization of inozitol lipids in isolated rat-liver nuclei. Biochem. J. 327:1997;569-576.
27. Mellgren R.L., Lu Q. Selective nuclear transport of mu-calpain. Biochem. Biophys. Res. Commun. 204:1994;544-550.
28. Mellgren R.L. Proteolysis of nuclear proteins by mu-calpain and m-calpain. J. Biol. Chem. 266:1991;13920-13924.
29. Molinari M., Carafoli E. Calpain: a cytosolic proteinase active at the membranes. J. Membr. Biol. 156:1997;1-8.
30. Turner S.J., Domin J., Waterfield M.D., Ward S.G., Westwick J. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha. J. Biol. Chem. 273:1998;25987-25995.
31. Brown R.A., Domin J., Arcaro A., Waterfield M.D., Shepherd P.R. Insulin activates the alpha isoform of class II phosphoinositide 3-kinase. J. Biol. Chem. 274:1999;14529-14532.
32. Arcaro A., Zvelebil M.J., Wallasch C., Ullrich A., Waterfield M.D., Domin J. Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors. Mol. Cell. Biol. 20:2000;3817-3830.
33. Domin J., Gaidarov I., Smith M.E., Keen J.H., Waterfield M.D. The class II phosphoinositide 3-kinase PI3K-C2alpha is concentrated in the trans-Golgi network and present in clathrin-coated vesicles. J. Biol. Chem. 275:2000;11943-11950.
34. Didichenko S.A., Thelen M. Phosphatidylinositol 3-kinase C2alpha contains a nuclear localization sequence and associates with nuclear speckles. J. Biol. Chem. 276:2001;48135-48142.
35. Wheeler M., Domin J. Recruitment of the class II phosphoinositide 3-kinase C2beta to the epidermal growth factor receptor: role of Grb2. Mol. Cell. Biol. 21:2001;6660-6667.
36. Gaidarov I., Smith M.E., Domin J., Keen J.H. The class II phosphoinositide 3-kinase C2alpha is activated by clathrin and regulates clathrin-mediated membrane trafficking. Mol. Cell. 7:2001;443-449.
37. Bertagnolo V., Marchisio M., Volinia S., Caramelli E., Capitani S. Nuclear association of tyrosine-phosphorylated Vav to phospholipase C-gamma1 and phosphoinositide 3-kinase during granulocytic differentiation of HL-60 cells. FEBS Lett. 441:1998;480-484.
38. Ye K., Hurt K.J., Wu F.Y., Fang M., Luo H.R., Hong J.J., Blackshaw S., Ferris C.D., Snyder S.H. Pike. A nuclear GTPase that enhances PI3kinase activity and is regulated by protein 4.1N. Cell. 103:2000;919-930.
39. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Ann. Rev. Biochem. 70:2001;535-602.
40. Simonsen A., Stenmark H. PX domains: attracted by phosphoinositides. Nat. Cell Biol. 3:2001;E179-E182.
41. Wishart M.J., Taylor G.S., Dixon J.E. Phoxy lipids: revealing PX domains as phosphoinositide binding modules. Cell. 105:2001;817-820.